AFM11, a CD19/CD3 bispecific tandab, to facilitate T-cell-mediated killing of CD19+ cells.
Eugene Zhukovsky
Employment or Leadership Position - Affimed Therapeutics
Stock Ownership - Affimed Therapeutics
Uwe Reusch
Employment or Leadership Position - Affimed Therapeutics
Carmen Burkhardt
Employment or Leadership Position - Affimed Therapeutics
Stefan Knackmuss
Employment or Leadership Position - Affimed Therapeutics
Ivica Fucek
Employment or Leadership Position - Affimed Therapeutics
Markus Eser
Employment or Leadership Position - Affimed Therapeutics
Fionnuala McAleese
Employment or Leadership Position - Affimed Therapeutics
Kristina Ellwanger
Employment or Leadership Position - Affimed Therapeutics
Melvyn Little
Consultant or Advisory Role - Affimed Therapeutics
Stock Ownership - Affimed Therapeutics